AptarGroup, Inc. (NYSE:ATR) price target raised to $105.00 by Robert W. Baird

ME Staff
-
0

Analyst Ratings For AptarGroup, Inc. (NYSE:ATR)

Today, Robert W. Baird raised its price target on AptarGroup, Inc. (NYSE:ATR) to $105.00 per share.

There are 7 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on AptarGroup, Inc. (NYSE:ATR) is Hold with a consensus target price of $99.4286 per share, a potential 3.05% downside.

Some recent analyst ratings include

  • 6/20/2018-UBS Group initiated coverage with a Neutral rating.
  • 5/18/2018-Jefferies Financial Group initiated coverage with a Hold rating.
  • 4/27/2018-KeyCorp Reiterated Rating of Hold.
  • 2/14/2018-Wells Fargo & Co Reiterated Rating of Market Perform.

Recent Insider Trading Activity For AptarGroup, Inc. (NYSE:ATR)
AptarGroup, Inc. (NYSE:ATR) has insider ownership of 3.40% and institutional ownership of 89.57%.

  • On 6/26/2018 Salim Haffar, Insider, sold 10,514 with an average share price of $92.95 per share and the total transaction amounting to $977,276.30.
  • On 6/21/2018 Salim Haffar, Insider, sold 7,616 with an average share price of $93.88 per share and the total transaction amounting to $714,990.08.
  • On 5/8/2018 Stephen J Hagge, Director, sold 25,000 with an average share price of $91.98 per share and the total transaction amounting to $2,299,500.00.
  • On 5/1/2018 King W Harris, Director, sold 50,000 with an average share price of $93.29 per share and the total transaction amounting to $4,664,500.00.
  • On 3/13/2018 Ursula Saint-Leger, Insider, sold 66,493 with an average share price of $90.53 per share and the total transaction amounting to $6,019,611.29.
  • On 3/9/2018 King W Harris, Director, sold 68,985 with an average share price of $89.99 per share and the total transaction amounting to $6,207,960.15.
  • On 3/2/2018 Stephen J Hagge, Director, sold 5,612 with an average share price of $88.65 per share and the total transaction amounting to $497,503.80.

About AptarGroup, Inc. (NYSE:ATR)
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates in three segments: Beauty + Home, Pharma, and Food + Beverage. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and household markets; and pumps and decorative components to the beauty market. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market. The Food + Beverage segment offers dispensing and non-dispensing closures, spray pumps, and aerosol valves to the food and beverage markets. The company also manufactures and sells elastomeric primary packaging components for injectable market, which include stoppers for infusion, antibiotic, lyophilization, and diagnostic vials; and pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, and dropper bulbs and syringe plungers. AptarGroup, Inc. sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company was founded in 1992 and is headquartered in Crystal Lake, Illinois.

Recent Trading Activity for AptarGroup, Inc. (NYSE:ATR)
Shares of AptarGroup, Inc. closed the previous trading session at 102.70 −0.21 0.20% with 99.95 shares trading hands.